Myelodysplastic Syndrome and Histone Deacetylase Inhibitors: “To Be or Not to Be Acetylated”?

Myelodysplastic syndrome (MDS) represents a heterogeneous group of diseases with clonal proliferation, bone marrow failure and increasing risk of transformation into an acute myeloid leukaemia. Structured guidelines are developed for selective therapy based on prognostic subgroups, age, and performa...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Stintzing, Sebastian, Kemmerling, Ralf, Kiesslich, Tobias, Alinger, Beate, Ocker, Matthias, Neureiter, Daniel
Формат: Artigo
Язык:Inglês
Опубликовано: Hindawi Publishing Corporation 2011
Предметы:
Review Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3100562/
https://ncbi.nlm.nih.gov/pubmed/21629744
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2011/214143
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы